Savant Capital’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Savant Capital's AQST Position: Q3 2026 in Review
Savant Capital reduced its Aquestive Therapeutics (AQST) stake by 3.5% in Q3 2026, selling an estimated $2.48K and leaving 15,462 shares worth $71.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.
Savant Capital first reported a position in AQST in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Savant Capital held 15,462 shares of Aquestive Therapeutics worth $71.6K as of Q3 2026.
- Savant Capital sold 559 Aquestive Therapeutics shares in Q3 2026, an estimated $2.48K.
- Aquestive Therapeutics made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #2354 holding.
- Savant Capital first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.